Chunyan Chen Selected Research

Colitis

11/2023	Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway.
1/2019	Is dextran sulfate sodium a good inducer of acute experimental enteritis?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunyan Chen Research Topics

Disease

33	Neoplasms (Cancer) 12/2023 - 10/2007
12	Carcinogenesis 09/2023 - 03/2010
9	Neoplasm Metastasis (Metastasis) 11/2023 - 10/2007
9	Stomach Neoplasms (Stomach Cancer) 01/2021 - 03/2010
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2024 - 08/2014
8	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 03/2011
7	Nasopharyngeal Carcinoma 01/2021 - 11/2013
6	Infections 03/2016 - 02/2010
5	Inflammation (Inflammations) 01/2022 - 01/2018
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2018
4	Carcinoma (Carcinomatosis) 01/2021 - 01/2015
3	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2024 - 01/2023
3	Reperfusion Injury 01/2023 - 01/2018
3	Ischemia 01/2023 - 01/2018
3	Blast Crisis (Blast Phase) 10/2022 - 01/2015
2	Fatty Liver 02/2024 - 01/2023
2	Colitis 11/2023 - 01/2019
2	Bacterial Infections (Bacterial Infection) 11/2023 - 02/2010
2	Melanoma (Melanoma, Malignant) 09/2023 - 05/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2023 - 05/2015
2	Body Weight (Weight, Body) 06/2023 - 01/2023
2	Fibrosis (Cirrhosis) 01/2023 - 12/2014
2	Disease Progression 10/2022 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 08/2012
2	Anemia 04/2021 - 01/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2013
2	Hypoxia (Hypoxemia) 01/2019 - 11/2018
2	Necrosis 06/2017 - 01/2017
2	Gastritis 03/2016 - 10/2011
2	Vascular Remodeling 07/2015 - 12/2014
1	Ventricular Tachycardia 02/2024
1	Pancreatitis 02/2024
1	Asthma (Bronchial Asthma) 01/2024
1	Lung Injury 01/2024
1	Hypercapnia 01/2024
1	Respiratory Insufficiency (Respiratory Failure) 01/2024
1	Disease Resistance 12/2023
1	Rectal Neoplasms (Rectal Cancer) 12/2023
1	Ulcerative Colitis 11/2023
1	Osteosarcoma (Osteogenic Sarcoma) 11/2023
1	Fistula 10/2023
1	Parkinson Disease (Parkinson's Disease) 10/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2007
8	MicroRNAs (MicroRNA)IBA 08/2023 - 08/2012
8	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2015
7	Histone DemethylasesIBA 11/2019 - 01/2013
5	Messenger RNA (mRNA)IBA 10/2023 - 03/2011
5	Therapeutic UsesIBA 01/2023 - 01/2015
4	Histones (Histone)IBA 01/2021 - 01/2015
3	Long Noncoding RNAIBA 01/2023 - 01/2022
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 04/2020 - 01/2019
3	Folic Acid (Vitamin M)FDA LinkGeneric 04/2020 - 01/2008
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 10/2014
2	flumatinibIBA 04/2024 - 02/2024
2	EVT 201IBA 02/2024 - 02/2024
2	Polysaccharides (Glycans)IBA 11/2023 - 09/2012
2	NF-kappa B (NF-kB)IBA 11/2023 - 01/2021
2	auristatinIBA 04/2023 - 12/2022
2	Immunoconjugates (Immunoconjugate)IBA 04/2023 - 12/2022
2	LipopolysaccharidesIBA 01/2023 - 01/2022
2	Retinaldehyde (Retinal)IBA 01/2023 - 01/2023
2	ProteomeIBA 01/2023 - 12/2013
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2023
2	Indicators and Reagents (Reagents)IBA 12/2022 - 03/2016
2	Histone ChaperonesIBA 10/2022 - 12/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2016
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 01/2019
2	CytokinesIBA 01/2021 - 01/2019
2	Lipid NanoparticlesIBA 04/2020 - 10/2019
2	Oxygen (Dioxygen)IBA 04/2020 - 10/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019 - 04/2014
2	Contrast MediaIBA 10/2019 - 01/2008
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2018 - 04/2012
2	Cadherins (E-Cadherin)IBA 07/2015 - 01/2014
2	Serotonin (5 Hydroxytryptamine)IBA 07/2015 - 12/2014
1	Dasatinib (BMS 354825)FDA Link 02/2024
1	Imatinib Mesylate (Gleevec)FDA Link 02/2024
1	nilotinib FDA Link 02/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2024
1	Adenosine Triphosphate (ATP)IBA 12/2023
1	MucinsIBA 11/2023
1	Glutathione (Reduced Glutathione)IBA 10/2023
1	LipidsIBA 10/2023

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2024 - 01/2008
9	Therapeutics 02/2024 - 01/2016
5	Radiotherapy 11/2023 - 10/2014
3	Lasers (Laser) 10/2019 - 11/2018
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 07/2016 - 11/2013
2	Neoadjuvant Therapy 12/2023 - 01/2017
2	Immunotherapy 01/2022 - 01/2021
2	Oral Administration 04/2021 - 01/2019
2	Photothermal Therapy 04/2020 - 10/2019
2	Aftercare (After-Treatment) 10/2019 - 03/2014
2	Chemoradiotherapy 01/2017 - 11/2013
1	Catheter Ablation 02/2024
1	Artificial Respiration (Mechanical Ventilation) 01/2024
1	Mechanical Ventilators (Ventilator) 01/2024
1	Intralesional Injections 10/2023